|
126
|
313
|
5sdzA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-[3-[2,3-dihydroxypropyl(methyl)carbamoyl]-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
129
|
313
|
5sjaA |
Crystal structure of human phosphodiesterase 10 in complex with n-(2-tert-butyl-5-methylpyrazol-3-yl)-1-phenyl-3-(pyridin-2-yloxymethyl)thieno[2,3-c]pyrazole-5-carboxamide |
|
122
|
314
|
5sgmA |
Crystal structure of human phosphodiesterase 10 in complex with 3-n-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-7-yl]-4-n,4-n,2-trimethylpyrazole-3,4-dicarboxamide |
|
121
|
312
|
5sgnA |
Crystal structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-7-(trifluoromethyl)imidazo[1,2-b]pyridazine |
|
126
|
313
|
5sgsA |
Crystal structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-pyridin-2-ylpyrrolidin-3-yl)ethyl]quinoxaline |
|
124
|
313
|
5sgkA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-[(7r)-2-(2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl]pyrazole-3-carboxamide |
|
126
|
313
|
5sfvA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-n-(1-cyclopentylpyrazol-3-yl)-2-methylpyrazole-3-carboxamide |
|
124
|
313
|
5sftA |
Crystal structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
126
|
314
|
5sjxA |
Crystal structure of human phosphodiesterase 10 in complex with 2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline |
|
122
|
313
|
5sjjA |
Crystal structure of human phosphodiesterase 10 in complex with 4-n-ethyl-5-[3-(trifluoromethyl)phenyl]-7h-pyrrolo[2,3-d]pyrimidine-2,4-diamine |
|
121
|
313
|
5shjA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-[3-(phenylcarbamoyl)phenyl]pyrazole-3-carboxamide |
|
124
|
312
|
5sidA |
Crystal structure of human phosphodiesterase 10 in complex with 5-chloro-2-[2-(6,8-dichloro-5-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)ethyl]-1,3-benzothiazole |
|
125
|
315
|
5siiA |
Crystal structure of human phosphodiesterase 10 in complex with 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine |
|
125
|
312
|
5skoA |
Crystal structure of human phosphodiesterase 10 in complex with n-(3-imidazo[1,2-a]pyridin-2-ylphenyl)-1-methyl-3-(pyrimidin-5-ylamino)pyrazole-4-carboxamide |
|
125
|
313
|
5sjdA |
Crystal structure of human phosphodiesterase 10 in complex with 1-[2-(3,5-dimethylpyrazol-1-yl)ethyl]-3-(2-phenylpyrazol-3-yl)urea |
|
127
|
313
|
5si5A |
Crystal structure of human phosphodiesterase 10 in complex with n-(12-methoxy-5-methyl-3-propyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,7,9,11-hexaen-7-yl)methanesulfonamide |
|
124
|
313
|
5sifA |
Crystal structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-yl]-1-(3-methylsulfonylphenyl)pyridazin-4-one |
|
123
|
313
|
5sj5A |
Crystal structure of human phosphodiesterase 10 in complex with 6-chloroquinoxalin-2-amine |
|
124
|
313
|
5skaA |
Crystal structure of human phosphodiesterase 10 in complex with 7-[(4-ethoxy-5-methylpyridin-2-yl)methylsulfanyl]-6h-imidazo[4,5-g][1,3]benzothiazole |
|
123
|
313
|
5siaA |
Crystal structure of human phosphodiesterase 10 in complex with 1-(2,3-dimethylquinoxalin-6-yl)-3-(3-methoxyphenyl)urea |
|
124
|
313
|
5sipA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide |
|
123
|
313
|
5shuA |
Crystal structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-3,5,6,7-tetrahydropyrrolo[3,2-f]benzimidazole |
|
124
|
311
|
5sg7A |
Crystal structure of human phosphodiesterase 10 in complex with 3-[2-(2-fluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one |
|
125
|
313
|
5sgzA |
Crystal structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-methyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,9,11-pentaen-7-one |
|
125
|
313
|
5siwA |
5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-8-(trifluoromethyl)-[1,2,4]triazolo[1,5-c]pyrimidine |
|
127
|
316
|
5sixA |
Crystal structure of human phosphodiesterase 10 in complex with 5-[(3r)-3-fluoropyrrolidin-1-yl]-2-(3-methylquinoxalin-2-yl)-n-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine |
|
127
|
314
|
5siqA |
Crystal structure of human phosphodiesterase 10 in complex with 2-ethyl-3-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]quinoxaline |
|
127
|
313
|
5shgA |
Crystal structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-methyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7,10,12-hexaen-7-amine |
|
122
|
313
|
5shhA |
Crystal structure of human phosphodiesterase 10 in complex with 7-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-6h-imidazo[4,5-g][1,3]benzothiazole |
|
125
|
313
|
5sj4A |
Crystal structure of human phosphodiesterase 10 in complex with 1-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-5h-pyrazolo[3,4-d]pyrimidin-4-one |
|
82
|
304
|
7mb2A |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor sm144 |
|
125
|
313
|
5sfrA |
Crystal structure of human phosphodiesterase 10 in complex with 4-n-ethyl-3-n-[2-[3-(2-fluoroethoxy)phenyl]imidazo[1,2-a]pyrimidin-7-yl]-4-n,2-dimethylpyrazole-3,4-dicarboxamide |
|
121
|
313
|
5seiA |
Crystal structure of human phosphodiesterase 10 in complex with 6-chloro-2-[(e)-2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethenyl]-[1,2,4]triazolo[1,5-a]pyridine |
|
121
|
313
|
5sekA |
Crystal structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]quinoxaline |
|
124
|
313
|
5sf7A |
Crystal structure of human phosphodiesterase 10 in complex with 1-(2-chlorophenyl)-8-methoxy-3,4-dimethylimidazo[1,5-a]quinazolin-5-one |
|
128
|
315
|
5se1A |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-[3-(dimethylcarbamoyl)-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
125
|
313
|
5sfaA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-[(1-methyl-4-phenylimidazol-2-yl)methoxy]-n-(oxolan-3-yl)pyrazine-2-carboxamide |
|
125
|
313
|
5sk0A |
Crystal structure of human phosphodiesterase 10 in complex with n-[(3r)-1-(5-chloropyridin-2-yl)pyrrolidin-3-yl]-1-methyl-4-pyridin-4-ylpyrazole-3-carboxamide |
|
127
|
313
|
5sfjA |
Crystal structure of human phosphodiesterase 10 in complex with 2-methyl-3-n-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)-4-n-(pyridin-2-ylmethyl)pyrazole-3,4-dicarboxamide |
|
125
|
312
|
5sfdA |
Crystal structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(2-methyl-5-piperidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
130
|
313
|
5seeA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-(2-pyridin-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
125
|
316
|
5sewA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-[1-(2-methoxyethyl)-5-(methylcarbamoyl)pyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
126
|
313
|
5sjvA |
Crystal structure of human phosphodiesterase 10 in complex with 5-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]quinoxaline |
|
121
|
317
|
5sf2A |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-(3-oxo-1,2-dihydroisoindol-5-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
127
|
313
|
5skcA |
Crystal structure of human phosphodiesterase 10 in complex with 6-methyl-n-(1-propan-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
124
|
313
|
5sduA |
Crystal structure of human phosphodiesterase 10 in complex with 5-methyl-4-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-2-phenyl-1,3-oxazole |
|
123
|
313
|
5sjtA |
Crystal structure of human phosphodiesterase 10 in complex with 4-n,4-n,2-trimethyl-3-n-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide |
|
126
|
313
|
5seqA |
Crystal structure of human phosphodiesterase 10 in complex with 5,6,8-trimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
123
|
313
|
5seuA |
Crystal structure of human phosphodiesterase 10 in complex with 2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine |
|
141
|
456
|
7mdcA |
Full-length wildtype clbp inhibited by hexanoyl-d-asparagine boronic acid |
